Cancer risks among construction workers / Rischio di cancro tra i lavoratori edili
Keywords:
construction workers, cancer risks, materials in construction industry, asbestos, lavoratori edili, rischi cancerogeni, materiali in edilizia, amiantoAbstract
Numerous studies with different study designs from different parts of the world consistently show excess cancer risks in construction workers, compatible with exposures to products or agents possessing cancer risks in the different job categories. International Agency for Research on Cancer (IARC) has concluded that exposure as a painter is a group 1 carcinogen. Cement and silica dust exposures are associated with excess risks of respiratory cancers – in particular lung – but also of excess cancer of the lip, pharynx, esophagus and stomach. Asbestos exposure is shown to be associated with excess cancer of the larynx and lung and with mesotheliomas of the pleura and peritoneum among construction workers worldwide.Rischio di cancro tra i lavoratori edili
Numerosi studi, con approcci diversi da diverse parti del mondo, dimostrano regolarmente un eccesso di rischi cancerogeni nei lavoratori dell’edilizia. Tale eccesso è compatibile con esposizioni a prodotti o agenti potenzialmente cancerogeni nelle diverse categorie di lavoratori. La IARC ha concluso che l’esposizione alle sostanze a cui è sottoposto un imbianchino è un cancerogeno del gruppo 1. Le esposizioni alle polveri di silice e del cemento sono associate ad un eccesso di rischio di sviluppare il cancro delle vie respiratorie, in particolare del polmone ma anche delle labbra, della faringe, dell’esofago e dello stomaco. È stato dimostrato che l’esposizione ad amianto è associata ad un eccesso di rischio di cancro alla laringe ed al polmone e di mesotelioma della pleura e del peritoneo tra i lavoratori dell’edilizia in tutto il mondo.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.